Sperm DNA oxidative damage and DNA adducts
Based on practitioner reports and patient experience (not controlled clinical trials, which do not yet exist for IGF-1 LR3 in humans): Individual results vary based on training consistency, nutrition, dosing, genetics, and baseline fitness level
Looking toward the future The wheels of progress on multi-agonists, oral small molecules, and tissue-targeted approaches are moving forward at breakneck speed
Using a scientific yet accessible tone, we review how these therapies work, the clinical evidence supporting their use in EDS patients, and important considerations regarding their safety and limitations
Surgery in the Multimodality Approach to Esophageal Cancer